High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome

Recruiting Observational Study
Acute Coronary Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
240 (estimated)
Sponsor
Sohag University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients aged 18 Year or older presented by ACS not candidet for primary percutaneus coronary intervention ( PCI ) . Exclusion Criteria: * • Patients aged \< 18 years old * Patients who have eGFR \<60 ml/kg /m2 * Patients who have malignancies * Patients who have …
Contacts

Amira Elbasuony, resident

01113695925

amiraelbadawy518@gmail.com

CONTACT